Chantix is a prescription medication used to treat smoking addiction. This medication is the first approved nicotinic receptor partial agonist. Specifically, varenicline is a partial agonist of the alpha4/beta2 subtype of the nicotinic acetylcholine receptor. In addition it acts on alpha3/beta4 and weakly on alpha3beta2 and alpha6-containing receptors. A full agonism was displayed on alpha7-receptors.

Chantix - Pharmacology:

Chantix is an alpha-4 beta-2 neuronal nicotinic acetylcholine receptor agonist. The drug shows high selectiviyty for this receptor subclass, relative to other nicotinic receptors (>500-fold alpha-3 beta-4, >3500-fold alpha-7, >20,000-fold alpha-1 beta gamma delta) or non-nicotinic receptors and transporters (>2000-fold). The drug competitively inhibits the ability of nicotine to bind to and activate the alpha-4 beta-2 receptor. The drug exerts mild agonistic activity at this site, though at a level much lower than nicotine; it is presumed that this activation eases withdrawal symptoms.

Chantix mini report

Chantix NDA
NDA - A product marketed under an approved New Drug Application
Chantix KIT
Chantix global name
varenicline tartrate
Start - Stop data
Start - Stop data
not occurred

Medicinal name:

  • Varenicline 0.5 MG Oral Tablet
  • Pack
  • Varenicline 1 MG Oral Tablet
  • Pack

Chantix for patients

  • Patients should be instructed to set a date to quit smoking and to initiate CHANTIX treatment one week before the quit date.
  • Patients should be advised that CHANTIX should be taken after eating, and with a full glass of water.
  • Patients should be instructed how to titrate CHANTIX, beginning at a dose of 0.5 mg/day. Prescribers should explain that one 0.5 mg tablet should be taken daily for the first three days, and that for the next four days, one 0.5 mg tablet should be taken in the morning and one 0.5 mg tablet should be taken in the evening.
  • Patients should be advised that, after the first seven days, the dose should be increased to one 1 mg tablet in the morning and one 1 mg tablet in the evening.
  • Patients should be encouraged to continue to attempt to quit if they have early lapses after quit day.
  • Patients should be informed that nausea and insomnia are side effects of CHANTIX and are usually transient; however, patients should be advised that if they are persistently troubled by these symptoms, they should notify the prescribing physician so that a dose reduction can be considered.
  • Patients should also be provided with educational materials and necessary counseling to support an attempt at quitting smoking.
  • Patients should be informed that some medications may require dose adjustment after quitting smoking,
  • Patients intending to become pregnant or planning to breast-feed an infant should be advised of the risks of smoking and risks and benefits of smoking cessation with CHANTIX.

Chantix Interactions

No clinically meaningful pharmacokinetic drug-drug interactions have been identified.

Brand Names containing Varenicline

Related brand
Adverse effect counter

Chantix tags categories:

Trusted Medical Info

Known as the Merck-KGaA manual in the US & Canada and as the MSD manual in the rest of the World

Manufacturers name:

  • Carilion Materials Management
  • Cardinal Health
  • Physicians Total Care, Inc
  • Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC
  • Rebel Distributors Corp
  • US Pharmaceuticals
  • Pfizer Laboratories Div Pfizer Inc

Generic name, Overdose, Half Life Chantix, Food Interactions, Chemical, etc..

Chantix see also

Chemical structure:
N H N N H H H H H H H H H H H H C13H13N3 2D chemical structure C13H13N3 SVG | 2D structure Varenicline chemical names, chemical properties, classification C13H13N3

Picture Chantix